Clinical Trial Update: Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing prasugrel with high-dose clopidogrel in clopidogrel-resistant patients undergoing chronic hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: University of Patras | Conditions: Hemodialysis, Chronic Renal Failure | Phase 3 | Status: COMPLETED